Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis

被引:89
作者
Koga, M
Gilbert, M
Takahashi, M
Li, JJ
Koike, S
Hirata, K
Yuki, N
机构
[1] Dokkyo Univ, Sch Med, Dept Neurol, Mibu, Tochigi 3210293, Japan
[2] Dokkyo Univ, Sch Med, Inst Med Sci, Mibu, Tochigi 3210293, Japan
[3] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Tokyo, Japan
[4] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada
关键词
D O I
10.1086/499969
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Guillain-Barre syndrome ( GBS), a postinfectious autoimmune-mediated neuropathy, is a serious complication after Campylobacter jejuni enteritis. Methods. To investigate the bacterial risk factors for developing GBS, genotypes, serotypes, and ganglioside mimics on lipo-oligosaccharide ( LOS) were analyzed in C. jejuni strains from Japanese patients. Results. Strains from patients with GBS had LOS biosynthesis locus class A more frequently ( 72/106; 68%) than did strains from patients with enteritis ( 17/103; 17%). Class A strains predominantly were serotype HS:19 and had the cstII ( Thr51) genotype; the latter is responsible for biosynthesis of GM1-like and GD1a-like LOSs. Both anti-GM1 and anti-GD1a monoclonal antibodies regularly bound to class A LOSs, whereas no or either antibody bound to other LOS locus classes. Mass-spectrometric analysis showed that a class A strain carried GD1a-like LOS as well as GM1-like LOS. Logistic regression analysis showed that serotype HS: 19 and the class A locus were predictive of the development of GBS. Conclusions. The high frequency of the class A locus in GBS-associated strains, which was recently reported in Europe, provides the first GBS-related C. jejuni characteristic that is common to strains from Asia and Europe. The class A locus and serotype HS: 19 seem to be linked to cstII polymorphism, resulting in promotion of both GM1-like and GD1a-like structure synthesis on LOS and, consequently, an increase in the risk of producing antiganglioside autoantibodies and developing GBS.
引用
收藏
页码:547 / 555
页数:9
相关论文
共 48 条
[1]   Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barre, and Miller Fisher patients [J].
Ang, CW ;
Laman, JD ;
Willison, HJ ;
Wagner, ER ;
Endtz, HP ;
De Klerk, MA ;
Tio-Gillen, AP ;
Van den Braak, N ;
Jacobs, BC ;
Van Doorn, PA .
INFECTION AND IMMUNITY, 2002, 70 (03) :1202-1208
[2]   ASSESSMENT OF CURRENT DIAGNOSTIC-CRITERIA FOR GUILLAIN-BARRE-SYNDROME [J].
ASBURY, AK ;
CORNBLATH, DR .
ANNALS OF NEUROLOGY, 1990, 27 :S21-S24
[3]   LIPOPOLYSACCHARIDES OF CAMPYLOBACTER-JEJUNI SEROTYPE-O-19 - STRUCTURES OF CORE OLIGOSACCHARIDE REGIONS FROM THE SEROSTRAIN AND 2 BACTERIAL ISOLATES FROM PATIENTS WITH THE GUILLAIN-BARRE-SYNDROME [J].
ASPINALL, GO ;
MCDONALD, AG ;
PANG, H ;
KURJANCZYK, LA ;
PENNER, JL .
BIOCHEMISTRY, 1994, 33 (01) :241-249
[4]   SERUM ANTI-GQ(1B) IGG ANTIBODY IS ASSOCIATED WITH OPHTHALMOPLEGIA IN MILLER FISHER SYNDROME AND GUILLAIN-BARRE-SYNDROME - CLINICAL AND IMMUNOHISTOCHEMICAL STUDIES [J].
CHIBA, A ;
KUSUNOKI, S ;
OBATA, H ;
MACHINAMI, R ;
KANAZAWA, I .
NEUROLOGY, 1993, 43 (10) :1911-1917
[5]   Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barre or Miller Fisher syndrome [J].
Duim, B ;
Ang, CW ;
van Belkum, A ;
Rigter, A ;
van Leeuwen, NWJ ;
Endtz, HP ;
Wagenaar, JA .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2000, 66 (09) :3917-3923
[6]  
Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297
[7]   Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barre syndrome and gastroenteritis [J].
Engberg, J ;
Nachamkin, I ;
Fussing, V ;
McKhann, GM ;
Griffin, JW ;
Piffaretti, JC ;
Nielsen, EM ;
Gerner-Smidt, P .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (02) :215-220
[9]   Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barre patients [J].
Geleijns, K ;
Jacobs, BC ;
Van Rijs, W ;
Tio-Gillen, AP ;
Laman, JD ;
van Doorn, PA .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 150 (1-2) :132-138
[10]  
Gilbert M, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P219